Experiments on mouse models of diabetes have shown that treatment of mice with a pan-Hsp90 inhibitor [62] and also knockdown of HSP90ab1 [63] have been found to improve glucose homeostasis and insulin sensitivity, suggesting a role of these chaperones in the pathogenesis of type diabetes. Here, HSP90AB1 is linked to diabetes mellitus.